LIVN Stock Summary and Trading Ideas (Livanova PLC - | NASDAQ:LIVN)

UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

Livanova PLC - trades on the NASDAQ stock market under the symbol LIVN.

As of April 18, 2024, LIVN stock price climbed to $52.00 with 19,145 million shares trading.

LIVN has a beta of 1.35, meaning it tends to be more sensitive to market movements. LIVN has a correlation of 0.17 to the broad based SPY ETF.

LIVN has a market cap of $2.80 billion. This is considered a Mid Cap stock.

Last quarter Livanova PLC - reported $310 million in Revenue and $.87 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.10.

In the last 3 years, LIVN stock traded as high as $93.89 and as low as $40.26.

The top ETF exchange traded funds that LIVN belongs to (by Net Assets): IJH, IWM, VXF, IWN, MDY.

LIVN has underperformed the market in the last year with a price return of +8.3% while the SPY ETF gained +22.8%. LIVN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +3.1% and -3.6%, respectively, while the SPY returned +6.5% and -3.4%, respectively.

LIVN support price is $50.71 and resistance is $53.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIVN stock will trade within this expected range on the day.